Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Glucokinase
    (12)
  • Phosphatase
    (8)
  • Autophagy
    (5)
  • Parasite
    (3)
  • Apoptosis
    (2)
  • Bcl-2 Family
    (1)
  • Caspase
    (1)
  • Cell Cycle Arrest
    (1)
  • Hydroxylase
    (1)
  • Others
    (5)
TargetMol | Tags By Natures
  • Renealmia
    (1)
TargetMol | Tags By ResearchField
  • Cancer
    (10)
  • Metabolism
    (5)
  • Immune System
    (3)
  • Inflammation
    (3)
  • Nervous System
    (3)
  • Infection
    (2)
  • Cardiovascular System
    (1)
  • Endocrine system
    (1)
Filter
Search Result
Results for "

pfk

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    18
    TargetMol | All_Pathways
  • Compound Libraries
    2
    TargetMol | Compound_Libraries
  • Natural Products
    1
    TargetMol | Natural_Products
  • Reagent Kits
    2
    TargetMol | Reagent_Kits
  • Recombinant Protein
    7
    TargetMol | Recombinant_Protein
  • Antibody Products
    17
    TargetMol | Antibody_Products
PFK-015
PFK15, PFK 015
T24554382-63-2
PFK-015 (PFK15) is an effective inhibitor of PFKFB3 (IC50: 110 nM) and inhibits PFKFB3 activity in Y cells (IC50: 20 nM).
  • $34
In Stock
Size
QTY
TargetMol | Citations Cited
PFK-158
T31051462249-75-7
PFK-158 is an effective and specific inhibitor PFKFB3.
  • $30
In Stock
Size
QTY
TargetMol | Citations Cited
Kaempferitrin
Lespenephryl, Lespenefril, Lespedin, Kaempferol 3,7-dirhamnoside
T3386482-38-2
Kaempferitrin (Lespenephryl) has antidepressant-like effect related to the serotonergic system, principally 5-HT1A. Kaempferitrin exerts cytotoxic and antitumor effects against HeLa cells. Kaempferitrin stimulates glucose-metabolizing enzymes, promotes glucose homeostasis. Kaempferitrin exerts immunostimulatory effects on immune responses mediated by splenocytes, macrophages, PBMC and NK cells. Kaempferitrin induces cytotoxic effects to include: cell cycle arrest in G1 phase and apoptosis via the intrinsic pathway in a caspase-dependent pathway.
  • $35
In Stock
Size
QTY
ML251
T643201486482-16-9
ML251 is a potent novel nanomolar inhibitor of T. brucei and T. cruzi phosphofructokinase[1]. ML251 inhibits T. brucei PFK (IC50=0.37 μM) and T. cruzi PFK (IC50=0.13 μM). ML251 can be used for the research of parasite[1].
  • $117
In Stock
Size
QTY
PFK-IN-1
T204311735303-62-5
PFK-IN-1 (compound 1) is an inhibitor of 6-phosphofructo-1-kinase (PFK), demonstrating IC50 values of 0.41 and 0.23 μM against T. brucei and T. cruzi PFK, respectively, and an ED50 of 15.18 μg/mL for T. brucei. The compound has a half-life of 9.7 minutes in rat liver microsomes and 408 minutes in mouse liver microsomes.
  • Inquiry Price
10-14 weeks
Size
QTY
AZ PFKFB3 26
T143651704740-52-2In house
AZ PFKFB3 26 is an effective and selective PFKFB3 inhibitor with an IC50 of 23 nM. The IC50s for PFKFB1 and PFKFB2 are 2.06 and 0.384 μM, respectively.
  • $30
In Stock
Size
QTY
PFKFB4-IN-1
T2137172664831-55-2
PFKFB4-IN-1 is a potent and selective ATP-competitive inhibitor of PFKFB4 (IC50 = 4.50 μM) that reduces intracellular PFKFB4 protein levels. It exhibits over 12-fold selectivity for PFKFB1/4 and PFKFB3/4 isoforms. PFKFB4-IN-1 inhibits cancer cell proliferation, induces apoptosis, and suppresses cell migration. It also hinders tumor growth in MDA-MB-231 xenograft mouse models. PFKFB4-IN-1 is applicable for studies related to breast cancer, lung cancer, and liver cancer.
  • Inquiry Price
10-14 weeks
Size
QTY
AZ-PFKFB3-67
AZPFKFB3-67, AZ-PFKFB367
T267301704741-11-6
AZ-PFKFB3-67 is a potent and selective PFKFB3 kinase inhibitor with an IC50=11nM for PFKFB3, reduces MCL-1, and inhibits angiogenesis by decreasing lactic acid production and ATP levels in endothelial cells (ECs) in tube-forming assays, and has neuroprotective effects.
  • $42
In Stock
Size
QTY
AZ-PFKFB3-67 quarterhydrate
T62894
AZ-PFKFB3-67 quarterhydrate is a selective and potent inhibitor of the metabolic kinase PFKFB3 kinase, acting on PFKFB3 (IC50: 11 nM), PFKFB2 (IC50: 159 nM) and PFKFB1 (IC50: 1130 nM).
  • $1,190
10-14 weeks
Size
QTY
PFKFB3-IN-2
T67874794552-84-4
PFKFB3-IN-2 is an inhibitor of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3). Anti-sense treatment against PFKFB3 has demonstrated a reduction in tumor growth rate in vivo.
  • $45
In Stock
Size
QTY
GSK 366
T114701953157-39-5
GSK 366 is a potent kynurenine-3-monooxygenase (KMO) inhibitor with IC50 values of 0.7 nM for P. fluorescens-KMO and 2.3 nM for human KMO.
  • $2,820
3-6 months
Size
QTY
KAN0438757
T117411451255-59-6
KAN0438757 is a selective and potent inhibitor of the metabolic kinase [PFKFB3] with an IC50 of 0.19 μM.
  • $103
In Stock
Size
QTY
LysRs-IN-2
T119202170696-76-9
LysRs-IN-2 is a lysine tRNA synthetase (KRS) inhibitor with antiparasitic activity that inhibits Plasmodium falciparum KRS (PfKRS) and Cryptosporidium minum KRS (CpKRS), and is used in the study of malaria infections.
  • $112
In Stock
Size
QTY
3PO
T2222318550-98-6
3PO is a small-molecule inhibitor of PFKFB3 (IC50: 22.9 μM), inhibiting the proliferation of several human malignant hematopoietic and adenocarcinoma cell lines (IC50: 1.4-24 μM). It suppresses glucose uptake, and decreases the intracellular concentration
  • $52
In Stock
Size
QTY
YZ9
T235526093-71-6
Y29 is a potent PFKFB3 inhibitor with an IC50 of 0.183 µM, acting as a competitive inhibitor against Fru-6-P with a Ki of 0.094 µM[1].
  • $30
In Stock
Size
QTY
(E)-3PO
3PO
T326013309-08-5
(E)-3PO is a PFKFB3 (6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase) inhibitor.
  • $32
In Stock
Size
QTY
TargetMol | Citations Cited
5MPN
5-MPN
T4056547208-82-2
5MPN is an orally active and selective inhibitor of 6-phosphofructokinase-2-kinase (PFKFB4) that competitively inhibits the F6P binding site and inhibits the proliferation of myeloma cells, and can be used in the study of myeloproliferative neoplasms.
  • $98
In Stock
Size
QTY
Stibophen
T21504415489-16-4
Stibophen is a potent antiparasitic agent effective against Litomosoides carinii, Dipetalonema witei, and Brugia pahangi. It inhibits lactate accumulation and phosphofructokinase (PFK) activity in adult filarial worms. Additionally, Stibophen suppresses PFK activity in Ascaris and Hymenolepis diminuta, without affecting mammalian liver PFK. It is utilized in studies of schistosomiasis and filarial infections.
  • Inquiry Price
Inquiry
Size
QTY